101 related articles for article (PubMed ID: 15189359)
1. Endocannabinoids accumulate in spinal cord of SOD1 G93A transgenic mice.
Witting A; Weydt P; Hong S; Kliot M; Moller T; Stella N
J Neurochem; 2004 Jun; 89(6):1555-7. PubMed ID: 15189359
[TBL] [Abstract][Full Text] [Related]
2. The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset.
Shoemaker JL; Seely KA; Reed RL; Crow JP; Prather PL
J Neurochem; 2007 Apr; 101(1):87-98. PubMed ID: 17241118
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional profiling in the lumbar spinal cord of a mouse model of amyotrophic lateral sclerosis: a role for wild-type superoxide dismutase 1 in sporadic disease?
D'Arrigo A; Colavito D; Peña-Altamira E; Fabris M; Dam M; Contestabile A; Leon A
J Mol Neurosci; 2010 Jul; 41(3):404-15. PubMed ID: 20177826
[TBL] [Abstract][Full Text] [Related]
4. Changes in endocannabinoid receptors and enzymes in the spinal cord of SOD1(G93A) transgenic mice and evaluation of a Sativex(®) -like combination of phytocannabinoids: interest for future therapies in amyotrophic lateral sclerosis.
Moreno-Martet M; Espejo-Porras F; Fernández-Ruiz J; de Lago E
CNS Neurosci Ther; 2014 Sep; 20(9):809-15. PubMed ID: 24703394
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of monoacylglycerol lipase as a therapeutic target in a transgenic mouse model of ALS.
Pasquarelli N; Engelskirchen M; Hanselmann J; Endres S; Porazik C; Bayer H; Buck E; Karsak M; Weydt P; Ferger B; Witting A
Neuropharmacology; 2017 Sep; 124():157-169. PubMed ID: 28373073
[TBL] [Abstract][Full Text] [Related]
6. Focal dysfunction of the proteasome: a pathogenic factor in a mouse model of amyotrophic lateral sclerosis.
Kabashi E; Agar JN; Taylor DM; Minotti S; Durham HD
J Neurochem; 2004 Jun; 89(6):1325-35. PubMed ID: 15189335
[TBL] [Abstract][Full Text] [Related]
7. Ultrastructural diversity of inclusions and aggregations in the lumbar spinal cord of SOD1-G93A transgenic mice.
Guo Y; Li C; Wu D; Wu S; Yang C; Liu Y; Wu H; Li Z
Brain Res; 2010 Sep; 1353():234-44. PubMed ID: 20637744
[TBL] [Abstract][Full Text] [Related]
8. Activation of Phosphotyrosine-Mediated Signaling Pathways in the Cortex and Spinal Cord of SOD1
Mallozzi C; Spalloni A; Longone P; Domenici MR
Neural Plast; 2018; 2018():2430193. PubMed ID: 30154836
[TBL] [Abstract][Full Text] [Related]
9. In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient.
Niessen HG; Angenstein F; Sander K; Kunz WS; Teuchert M; Ludolph AC; Heinze HJ; Scheich H; Vielhaber S
Exp Neurol; 2006 Oct; 201(2):293-300. PubMed ID: 16740261
[TBL] [Abstract][Full Text] [Related]
10. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
[TBL] [Abstract][Full Text] [Related]
11. Transgenic SOD1 G93A mice develop reduced GLT-1 in spinal cord without alterations in cerebrospinal fluid glutamate levels.
Bendotti C; Tortarolo M; Suchak SK; Calvaresi N; Carvelli L; Bastone A; Rizzi M; Rattray M; Mennini T
J Neurochem; 2001 Nov; 79(4):737-46. PubMed ID: 11723166
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effect of oxidized galectin-1 in a transgenic mouse model of amyotrophic lateral sclerosis.
Chang-Hong R; Wada M; Koyama S; Kimura H; Arawaka S; Kawanami T; Kurita K; Kadoya T; Aoki M; Itoyama Y; Kato T
Exp Neurol; 2005 Jul; 194(1):203-11. PubMed ID: 15899257
[TBL] [Abstract][Full Text] [Related]
13. Glutamate release induced by activation of glycine and GABA transporters in spinal cord is enhanced in a mouse model of amyotrophic lateral sclerosis.
Raiteri L; Zappettini S; Stigliani S; Paluzzi S; Raiteri M; Bonanno G
Neurotoxicology; 2005 Oct; 26(5):883-92. PubMed ID: 15885796
[TBL] [Abstract][Full Text] [Related]
14. Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues.
Watanabe M; Dykes-Hoberg M; Culotta VC; Price DL; Wong PC; Rothstein JD
Neurobiol Dis; 2001 Dec; 8(6):933-41. PubMed ID: 11741389
[TBL] [Abstract][Full Text] [Related]
15. Relationship of oxygen radical-induced lipid peroxidative damage to disease onset and progression in a transgenic model of familial ALS.
Hall ED; Andrus PK; Oostveen JA; Fleck TJ; Gurney ME
J Neurosci Res; 1998 Jul; 53(1):66-77. PubMed ID: 9670993
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effects of the cannabigerol quinone derivative VCE-003.2 in SOD1
Rodríguez-Cueto C; Santos-García I; García-Toscano L; Espejo-Porras F; Bellido M; Fernández-Ruiz J; Muñoz E; de Lago E
Biochem Pharmacol; 2018 Nov; 157():217-226. PubMed ID: 30076846
[TBL] [Abstract][Full Text] [Related]
17. Pyruvate slows disease progression in a G93A SOD1 mutant transgenic mouse model.
Park JH; Hong YH; Kim HJ; Kim SM; Kim MJ; Park KS; Sung JJ; Lee KW
Neurosci Lett; 2007 Feb; 413(3):265-9. PubMed ID: 17174029
[TBL] [Abstract][Full Text] [Related]
18. Metabolic progression markers of neurodegeneration in the transgenic G93A-SOD1 mouse model of amyotrophic lateral sclerosis.
Niessen HG; Debska-Vielhaber G; Sander K; Angenstein F; Ludolph AC; Hilfert L; Willker W; Leibfritz D; Heinze HJ; Kunz WS; Vielhaber S
Eur J Neurosci; 2007 Mar; 25(6):1669-77. PubMed ID: 17432958
[TBL] [Abstract][Full Text] [Related]
19. Early excitability changes in lumbar motoneurons of transgenic SOD1G85R and SOD1G(93A-Low) mice.
Pambo-Pambo A; Durand J; Gueritaud JP
J Neurophysiol; 2009 Dec; 102(6):3627-42. PubMed ID: 19828728
[TBL] [Abstract][Full Text] [Related]
20. Progressive loss of a glial potassium channel (KCNJ10) in the spinal cord of the SOD1 (G93A) transgenic mouse model of amyotrophic lateral sclerosis.
Kaiser M; Maletzki I; Hülsmann S; Holtmann B; Schulz-Schaeffer W; Kirchhoff F; Bähr M; Neusch C
J Neurochem; 2006 Nov; 99(3):900-12. PubMed ID: 16925593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
